Endovascular therapy in acute ischemic stroke: The way forward after results from the IMS 3, SYNTHESIS and MR Rescue trials

Abstract

Endovascular therapy (EVT) has gained vogue in the management of patients with acute stroke. Newer stent-retriever devices have led to better recanalization rates. In many centers, EVT is slowly being used as an add on to or in some instances, even as an alternative to intravenous tissue plasminogen activator (IV tPA). The publication of the results of the SYNTHESIS expansion, Interventional Management of Stroke III and Mechanical Retrieval Recanalization of Stroke Clots Using Embolectomy trials in 2013 has questioned the enthusiastic use of EVT in acute stroke. They demonstrate that EVT (using a variety of devices) is no superior to IV tPA in the management of acute stroke. In the light of these controversial findings, we review the current status of EVT in the management of acute stroke.

Key words

Acute stroke - clot retrieval - endovascular therapy - intravenous alteplase - stent retrievers

• References

• 1 Menon BK, Goyal M. Endovascular therapy in acute ischemic stroke: Where we are, the challenges we face and what the future holds. Expert Rev Cardiovasc Ther 2011; 9: 473-484
• 2 Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P. et al Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke 2010; 41: 2254-2258
• 3 Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke 2007; 38: 967-973
• 4 Goyal M, Menon BK, Courts SB, Hill MD, Demchuk AM. Penumbra pivotal stroke trial investigators, Calgary stroke program, and the Seaman MR research center. Effect of baseline CT scan appearance and time to recanalization on clinical outcomes in endovascular thrombectomy of acute ischemic strokes. Stroke 2011; 42: 93-97
• 5 Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: Sonographic classification and short-term improvement. Circulation 2001; 103: 2897-2902
• 6 Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP. et al Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005; 36: 1432-1438
• 7 Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS. et al Mechanical thrombectomy for acute ischemic stroke: Final results of the multi MERCI trial. Stroke 2008; 39: 1205-1212
• 8 Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40: 2761-2768
• 9 Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG. et al Solitaire flow restoration device versus the merci retriever in patients with acute ischaemic stroke (SWIFT): A randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-1249
• 10 Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA. et al Trevo versus merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): A randomised trial. Lancet 2012; 380: 1231-1240
• 11 Menon BK, Kochar P, Ah-Seng A, Almekhlafi MA, Modi J, Wong JH. et al Initial experience with a self-expanding retrievable stent for recanalization of large vessel occlusions in acute ischemic stroke. Neuroradiology 2012; 54: 147-154
• 12 Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD. et al Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-890
• 13 Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R. et al Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904-913
• 14 Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z. et al A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914-923
• 15 Broderick JP, Schroth G. What the SWIFT and TREVO II trials tell us about the role of endovascular therapy for acute stroke. Stroke 2013; 44: 1761-1764
• 16 IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke 2007; 38: 2127-2135
• 17 Khatri P, Neff J, Broderick JP, Khoury JC, Carrozzella J, Tomsick T. et al Revascularization end points in stroke interventional trials: Recanalization versus reperfusion in IMS-I. Stroke 2005; 36: 2400-2403
• 18 Almekhlafi MA, Eesa M, Menon BK, Demchuk AM, Goyal M. Ultrashort imaging to reperfusion time interval arrests core expansion in endovascular therapy for acute ischemic stroke. J Neurointerv Surg 2013; 5 (Suppl. 01) i58-i61
• 19 Goyal M. Acute stroke trials: The elephant in the room. Neuroradiology 2013; 55 (08) 929-931
• 20 Menon BK, Smith EE, Coutts SB, Welsh DG, Faber JE, Goyal M. et al Leptomeningeal collaterals are associated with modifiable metabolic risk factors. Ann Neurol 2013; 74 (02) 241-248
• 21 Menon BK, Saver JL, Prabhakaran S, Reeves M, Liang L, Olson DM. et al Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke 2012; 43: 2293-2299
• 22 Menon BK, Puetz V, Kochar P, Demchuk AM. ASPECTS and other neuroimaging scores in the triage and prediction of outcome in acute stroke patients. Neuroimaging Clin N Am 2011; 21: 407-423 xii
• 23 Menon BK, Smith EE, Modi J, Patel SK, Bhatia R, Watson TW. et al Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions. AJNR Am J Neuroradiol 2011; 32: 1640-1645
• 24 Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA. et al Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010; 30: 1214-1225